Finasteride is a 5-alpha-reductase inhibitor, branded as Propecia and supplied here as a 1mg tablet. It is studied for its role in inhibiting the conversion of testosterone to DHT and the associated androgen-signaling and hair-follicle pathways.

This tablet formulation is used in controlled laboratory workflows and in-vitro systems examining 5-alpha-reductase activity, DHT regulation, and androgen signaling. It is applied in structured research models characterizing compound activity and downstream pathway interactions.

Finasteride supports analytical studies and cell-based models involving 5-alpha-reductase inhibition, DHT and androgen-receptor signaling, and hair-follicle and scalp-related mechanisms. It is relevant for pathway characterization and assay development focused on androgen and dermatological mechanisms within controlled study frameworks.

Finasteride is suited for researchers and investigators studying 5-alpha-reductase inhibition, DHT regulation, and hair-follicle mechanisms within controlled study frameworks.